Daré Bioscience, Inc. (DARE)
0.7892
+0.05
(+6.58%)
USD |
NASDAQ |
Sep 25, 16:00
0.7892
0.00 (0.00%)
After-Hours: 19:59
Daré Bioscience Research and Development Expense (Annual) : 3.889M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.889M |
| December 31, 2024 | 14.26M |
| December 31, 2023 | 21.54M |
| December 31, 2022 | 30.04M |
| December 31, 2021 | 30.62M |
| December 31, 2020 | 20.77M |
| December 31, 2019 | 8.546M |
| December 31, 2018 | 6.414M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.9847M |
| December 31, 2016 | 27.30M |
| December 31, 2015 | 25.76M |
| December 31, 2014 | 11.65M |
| December 31, 2013 | 9.503M |
| December 31, 2012 | 15.46M |
| December 31, 2011 | 13.48M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 117.07M |
| Elite Pharmaceuticals, Inc. | 5.743M |
| Eton Pharmaceuticals, Inc. | 7.765M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |